Just having a quick look at this new CFO's credentials, he's a heavy hitter. Besides his Accounting background, he's been CFO for biotech/medical companies like GeneType and Opthea, so he's definitaly been in the relevant circuit for years. Assuming I'm looking at the right dude's info, his income at Opthea was circa $470k! So, he aint cheap. IMU must have some big big financial goals in the pipe to invest in this guy.
Guess we'll see come September when he has his feet under the desk.
My own Google search, could be right, could be wrong. DYOR.
Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-40
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $521.9K | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1612511 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 3882781 | 14 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |